This study is collecting and storing blood and tissue samples from people with malignant melanoma (a type of skin cancer) and healthy individuals. The goal is to better understand what causes melanoma and how it behaves. By storing these samples, researchers hope to make new discoveries that could help diagnose or treat melanoma in the future. You can join if you have malignant melanoma or a personal history of melanoma, or if you are a healthy donor. The study is looking for new markers that can predict how melanoma will progress, which will be measured up to 3 months after collection. The current recruitment status is unclear.

Study design

This is an observational study planning to enroll 1000 participants. It involves collecting blood and tissue samples.

What's involved

You would provide blood samples at diagnosis, before treatments, at progression or recurrence, and annually (up to 4 times a year). Tissue samples may also be collected during standard medical procedures. Healthy individuals provide blood samples up to 4 times over one year.

Compensation

Not stated in the trial record.

Follow-up

New prognostic markers will be measured up to 3 months after collection.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.